New combo therapy aims to cut disability after 'silent' strokes
NCT ID NCT07252544
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether two medicines, isosorbide mononitrate and butylphthalide, can reduce disability in people who recently had a lacunar stroke (a small stroke deep in the brain). About 3,156 adults aged 30 and older will receive one or both drugs or placebos for up to a year. The goal is to see if these treatments help prevent long-term problems like trouble walking, thinking, or having another heart or brain event.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBRAL SMALL VESSEL DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a second Clot-Buster boost stroke recovery?
- The eyes may hold a window to brain health: a trial tests a new marker and treatment
- Can a Low-Dose clot buster boost recovery after stroke clot removal?
- Stroke treatment upgrade: adding a Clot-Buster after clot removal may boost recovery
- Could lying Head-Down help stroke patients? new trial aims to find out
- New home therapy boosts confidence after stroke